Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 479 entries
Sorted by: Best Match Show Resources per page
Catching up: The role of state science and technology policy in open innovation

EPSCoR Research Infrastructure Improvement Program AND Program Evaluation

Mayer H.
GSID: 8CSTP1tNJqoJ
H Mayer - Economic Development Quarterly, 2010 - journals.sagepub.com

This article examines the impact of the emerging model of open innovation on state public policy, particularly the practice of technology-based economic development in weak research and development (R&D) states. Open innovation describes the nascent practice of firms using...

Cite
Mayer, H. (2010). Catching up: The role of state science and technology policy in open innovation. Economic Development Quarterly, 24(3), 195-209.
Mayer, Heike. "Catching up: The role of state science and technology policy in open innovation." Economic Development Quarterly 24.3 (2010): 195-209.
Copy Download .nbib Format: MLA
Coexistence of adenomyosis uteri and endometrial cancer is associated with an improved prognosis compared with endometrial cancer only.

Oncology letters

Hertlein L, Rath J, Zeder-Göss C, Fürst S, Bayer D, Trillsch F, Mahner S, Burges A, Jeschke U.
PMID: 28927080
Oncol Lett. 2017 Sep;14(3):3302-3308. doi: 10.3892/ol.2017.6592. Epub 2017 Jul 18.

The present study aimed to identify differences in protein expression in cases of endometrioid endometrial cancer (EEC) with and without coexisting adenomyosis uteri (AM), and to evaluate the histopathological and prognostic distinctions. The total cohort included 22 patients in...

Cite
Hertlein L, Rath J, Zeder-Göss C, et al. Coexistence of adenomyosis uteri and endometrial cancer is associated with an improved prognosis compared with endometrial cancer only. Oncol Lett. 2017;14(3):3302-3308doi: 10.3892/ol.2017.6592.
Hertlein, L., Rath, J., Zeder-Göss, C., Fürst, S., Bayer, D., Trillsch, F., Mahner, S., Burges, A., & Jeschke, U. (2017). Coexistence of adenomyosis uteri and endometrial cancer is associated with an improved prognosis compared with endometrial cancer only. Oncology letters, 14(3), 3302-3308. https://doi.org/10.3892/ol.2017.6592
Hertlein, Linda, et al. "Coexistence of adenomyosis uteri and endometrial cancer is associated with an improved prognosis compared with endometrial cancer only." Oncology letters vol. 14,3 (2017): 3302-3308. doi: https://doi.org/10.3892/ol.2017.6592
Hertlein L, Rath J, Zeder-Göss C, Fürst S, Bayer D, Trillsch F, Mahner S, Burges A, Jeschke U. Coexistence of adenomyosis uteri and endometrial cancer is associated with an improved prognosis compared with endometrial cancer only. Oncol Lett. 2017 Sep;14(3):3302-3308. doi: 10.3892/ol.2017.6592. Epub 2017 Jul 18. PMID: 28927080; PMCID: PMC5588003.
Copy Download .nbib Format: NLM
SU-E-T-561: A Comparative Study of Single Verses Two Field Daily Fraction for Treatment of Prostate Cancer Using IMPT, Double-Scattered, and SUFD Delivery Technique.

Medical physics

Arjomandy B, Schultz T, Park S, Gayar H.
PMID: 28517092
Med Phys. 2012 Jun;39(6):3834. doi: 10.1118/1.4735650.

PURPOSE: We conducted an investigation to evaluate the robustness of different proton therapy delivery technique for treatment of prostate cancer. Three commonly used delivery techniques; intensity modulated, double-scattered, and single field uniform dose delivery was investigated for one field...

Cite
Arjomandy B, Schultz T, Park S, et al. SU-E-T-561: A Comparative Study of Single Verses Two Field Daily Fraction for Treatment of Prostate Cancer Using IMPT, Double-Scattered, and SUFD Delivery Technique. Med Phys. 2012;39(6):3834doi: 10.1118/1.4735650.
Arjomandy, B., Schultz, T., Park, S., & Gayar, H. (2012). SU-E-T-561: A Comparative Study of Single Verses Two Field Daily Fraction for Treatment of Prostate Cancer Using IMPT, Double-Scattered, and SUFD Delivery Technique. Medical physics, 39(6), 3834. https://doi.org/10.1118/1.4735650
Arjomandy, B, et al. "SU-E-T-561: A Comparative Study of Single Verses Two Field Daily Fraction for Treatment of Prostate Cancer Using IMPT, Double-Scattered, and SUFD Delivery Technique." Medical physics vol. 39,6 (2012): 3834. doi: https://doi.org/10.1118/1.4735650
Arjomandy B, Schultz T, Park S, Gayar H. SU-E-T-561: A Comparative Study of Single Verses Two Field Daily Fraction for Treatment of Prostate Cancer Using IMPT, Double-Scattered, and SUFD Delivery Technique. Med Phys. 2012 Jun;39(6):3834. doi: 10.1118/1.4735650. PMID: 28517092.
Copy Download .nbib Format: NLM
Calcium Hydride Catalyzed Highly 1,2-Selective Pyridine Hydrosilylation.

Chemistry (Weinheim an der Bergstrasse, Germany)

Intemann J, Bauer H, Pahl J, Maron L, Harder S.
PMID: 26120024
Chemistry. 2015 Aug 03;21(32):11452-61. doi: 10.1002/chem.201501072. Epub 2015 Jun 26.

Reaction of the calcium hydride complex (DIPPnacnac-CaH⋅THF)2 with pyridine is much faster and selective than that of the corresponding magnesium hydride complex (DIPPnacnac = [(2,6-iPr2 C6 H3 )NC(Me)]2 CH). With a range of pyridine, picoline and quinoline substrates, exclusive...

Cite
Intemann J, Bauer H, Pahl J, et al. Calcium Hydride Catalyzed Highly 1,2-Selective Pyridine Hydrosilylation. Chemistry. 2015;21(32):11452-61doi: 10.1002/chem.201501072.
Intemann, J., Bauer, H., Pahl, J., Maron, L., & Harder, S. (2015). Calcium Hydride Catalyzed Highly 1,2-Selective Pyridine Hydrosilylation. Chemistry (Weinheim an der Bergstrasse, Germany), 21(32), 11452-61. https://doi.org/10.1002/chem.201501072
Intemann, Julia, et al. "Calcium Hydride Catalyzed Highly 1,2-Selective Pyridine Hydrosilylation." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 21,32 (2015): 11452-61. doi: https://doi.org/10.1002/chem.201501072
Intemann J, Bauer H, Pahl J, Maron L, Harder S. Calcium Hydride Catalyzed Highly 1,2-Selective Pyridine Hydrosilylation. Chemistry. 2015 Aug 03;21(32):11452-61. doi: 10.1002/chem.201501072. Epub 2015 Jun 26. PMID: 26120024.
Copy Download .nbib Format: NLM
The National Institutes of Health Affordable Cancer Technologies Program: Improving Access to Resource-Appropriate Technologies for Cancer Detection, Diagnosis, Monitoring, and Treatment in Low- and Middle-Income Countries.

IEEE journal of translational engineering in health and medicine

Pearlman PC, Divi R, Gwede M, Tandon P, Sorg BS, Ossandon MR, Agrawal L, Pai V, Baker H, Lash TB.
PMID: 27730015
IEEE J Transl Eng Health Med. 2016 Sep 08;4:2800708. doi: 10.1109/JTEHM.2016.2604485. eCollection 2016.

Point-of-care (POC) technologies have proved valuable in cancer detection, diagnosis, monitoring, and treatment in the developed world, and have shown promise in low-and-middle-income countries (LMIC) as well. Despite this promise, the unique design constraints presented in low-resource settings, coupled...

Cite
Pearlman PC, Divi R, Gwede M, et al. The National Institutes of Health Affordable Cancer Technologies Program: Improving Access to Resource-Appropriate Technologies for Cancer Detection, Diagnosis, Monitoring, and Treatment in Low- and Middle-Income Countries. IEEE J Transl Eng Health Med. 2016;4:2800708doi: 10.1109/JTEHM.2016.2604485.
Pearlman, P. C., Divi, R., Gwede, M., Tandon, P., Sorg, B. S., Ossandon, M. R., Agrawal, L., Pai, V., Baker, H., & Lash, T. B. (2016). The National Institutes of Health Affordable Cancer Technologies Program: Improving Access to Resource-Appropriate Technologies for Cancer Detection, Diagnosis, Monitoring, and Treatment in Low- and Middle-Income Countries. IEEE journal of translational engineering in health and medicine, 42800708. https://doi.org/10.1109/JTEHM.2016.2604485
Pearlman, Paul C, et al. "The National Institutes of Health Affordable Cancer Technologies Program: Improving Access to Resource-Appropriate Technologies for Cancer Detection, Diagnosis, Monitoring, and Treatment in Low- and Middle-Income Countries." IEEE journal of translational engineering in health and medicine vol. 4 (2016): 2800708. doi: https://doi.org/10.1109/JTEHM.2016.2604485
Pearlman PC, Divi R, Gwede M, Tandon P, Sorg BS, Ossandon MR, Agrawal L, Pai V, Baker H, Lash TB. The National Institutes of Health Affordable Cancer Technologies Program: Improving Access to Resource-Appropriate Technologies for Cancer Detection, Diagnosis, Monitoring, and Treatment in Low- and Middle-Income Countries. IEEE J Transl Eng Health Med. 2016 Sep 08;4:2800708. doi: 10.1109/JTEHM.2016.2604485. eCollection 2016. PMID: 27730015; PMCID: PMC5052025.
Copy Download .nbib Format: NLM
Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells.

Oncotarget

Willibald M, Bayer G, Stahlhut V, Poschmann G, Stühler K, Gierke B, Pawlak M, Seeger H, Mueck AO, Niederacher D, Fehm T, Neubauer H.
PMID: 29069804
Oncotarget. 2017 Aug 02;8(42):72480-72493. doi: 10.18632/oncotarget.19819. eCollection 2017 Sep 22.

Menopausal hormone therapy, using estrogen and synthetic progestins, is associated with an increased risk of developing breast cancer. The effect of progestins on breast cells is complex and not yet fully understood. In previous

Cite
Willibald M, Bayer G, Stahlhut V, et al. Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells. Oncotarget. 2017;8(42):72480-72493doi: 10.18632/oncotarget.19819.
Willibald, M., Bayer, G., Stahlhut, V., Poschmann, G., Stühler, K., Gierke, B., Pawlak, M., Seeger, H., Mueck, A. O., Niederacher, D., Fehm, T., & Neubauer, H. (2017). Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells. Oncotarget, 8(42), 72480-72493. https://doi.org/10.18632/oncotarget.19819
Willibald, Marina, et al. "Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells." Oncotarget vol. 8,42 (2017): 72480-72493. doi: https://doi.org/10.18632/oncotarget.19819
Willibald M, Bayer G, Stahlhut V, Poschmann G, Stühler K, Gierke B, Pawlak M, Seeger H, Mueck AO, Niederacher D, Fehm T, Neubauer H. Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells. Oncotarget. 2017 Aug 02;8(42):72480-72493. doi: 10.18632/oncotarget.19819. eCollection 2017 Sep 22. PMID: 29069804; PMCID: PMC5641147.
Copy Download .nbib Format: NLM
Perceptions of internal medicine residency program candidates on the use of simulation in the selection process.

Journal of graduate medical education

Cannon K, Hartsell Z, Ivanov I, Charles J, Joshi H, Blair J, Geyer H.
PMID: 24949144
J Grad Med Educ. 2014 Jun;6(2):338-40. doi: 10.4300/JGME-D-13-00276.1.

BACKGROUND: The recruitment of skilled candidates into internal medicine residency programs has relied on traditional interviewing techniques with varying degrees of success. The development of simulated medical technology has provided a new arena in which to assess candidates' clinical...

Cite
Cannon K, Hartsell Z, Ivanov I, et al. Perceptions of internal medicine residency program candidates on the use of simulation in the selection process. J Grad Med Educ. 2014;6(2):338-40doi: 10.4300/JGME-D-13-00276.1.
Cannon, K., Hartsell, Z., Ivanov, I., Charles, J., Joshi, H., Blair, J., & Geyer, H. (2014). Perceptions of internal medicine residency program candidates on the use of simulation in the selection process. Journal of graduate medical education, 6(2), 338-40. https://doi.org/10.4300/JGME-D-13-00276.1
Cannon, Keith, et al. "Perceptions of internal medicine residency program candidates on the use of simulation in the selection process." Journal of graduate medical education vol. 6,2 (2014): 338-40. doi: https://doi.org/10.4300/JGME-D-13-00276.1
Cannon K, Hartsell Z, Ivanov I, Charles J, Joshi H, Blair J, Geyer H. Perceptions of internal medicine residency program candidates on the use of simulation in the selection process. J Grad Med Educ. 2014 Jun;6(2):338-40. doi: 10.4300/JGME-D-13-00276.1. PMID: 24949144; PMCID: PMC4054739.
Copy Download .nbib Format: NLM
PP113. NT-Pro-BNP: A predictor of adverse maternal outcomes in hypertensive gestational syndromes?.

Pregnancy hypertension

Cabo Fustaret MC, Escobar AM, Illia R, Uranga M, Rivas C, Lobenstein G, Olejnik P, Mayer H, Ramilo TP.
PMID: 26105436
Pregnancy Hypertens. 2012 Jul;2(3):301. doi: 10.1016/j.preghy.2012.04.224. Epub 2012 Jun 13.

INTRODUCTION: BNP (brain-type natriuretic peptide) is released by cardiomyocytes, as a pro-hormone, in response to parietal stress augmentation and systemic endothelial dysfunction, and then Pro-BNP is cleaved into: NT-Pro-BNP and BNP fragment in 1:1 ratio. BNP is considered an...

Cite
Cabo Fustaret MC, Escobar AM, Illia R, et al. PP113. NT-Pro-BNP: A predictor of adverse maternal outcomes in hypertensive gestational syndromes?. Pregnancy Hypertens. 2012;2(3):301doi: 10.1016/j.preghy.2012.04.224.
Cabo Fustaret, M. C., Escobar, A. M., Illia, R., Uranga, M., Rivas, C., Lobenstein, G., Olejnik, P., Mayer, H., & Ramilo, T. P. (2012). PP113. NT-Pro-BNP: A predictor of adverse maternal outcomes in hypertensive gestational syndromes?. Pregnancy hypertension, 2(3), 301. https://doi.org/10.1016/j.preghy.2012.04.224
Cabo Fustaret, M C, et al. "PP113. NT-Pro-BNP: A predictor of adverse maternal outcomes in hypertensive gestational syndromes?." Pregnancy hypertension vol. 2,3 (2012): 301. doi: https://doi.org/10.1016/j.preghy.2012.04.224
Cabo Fustaret MC, Escobar AM, Illia R, Uranga M, Rivas C, Lobenstein G, Olejnik P, Mayer H, Ramilo TP. PP113. NT-Pro-BNP: A predictor of adverse maternal outcomes in hypertensive gestational syndromes?. Pregnancy Hypertens. 2012 Jul;2(3):301. doi: 10.1016/j.preghy.2012.04.224. Epub 2012 Jun 13. PMID: 26105436.
Copy Download .nbib Format: NLM
Minimum Volume Standards in Surgery - Are We There Yet?.

Visceral medicine

Bauer H, Honselmann KC.
PMID: 28560225
Visc Med. 2017 May;33(2):106-116. doi: 10.1159/000456041. Epub 2017 Apr 13.

The quality of surgery is directly dependent on the quantity, more specifically, on the number of operations performed at a given hospital as well as on the designated surgeon. This fact is supported by numerous studies and meta-analyses that...

Cite
Bauer H, Honselmann KC. Minimum Volume Standards in Surgery - Are We There Yet?. Visc Med. 2017;33(2):106-116doi: 10.1159/000456041.
Bauer, H., & Honselmann, K. C. (2017). Minimum Volume Standards in Surgery - Are We There Yet?. Visceral medicine, 33(2), 106-116. https://doi.org/10.1159/000456041
Bauer, Hartwig, and Honselmann, Kim C. "Minimum Volume Standards in Surgery - Are We There Yet?." Visceral medicine vol. 33,2 (2017): 106-116. doi: https://doi.org/10.1159/000456041
Bauer H, Honselmann KC. Minimum Volume Standards in Surgery - Are We There Yet?. Visc Med. 2017 May;33(2):106-116. doi: 10.1159/000456041. Epub 2017 Apr 13. PMID: 28560225; PMCID: PMC5447172.
Copy Download .nbib Format: NLM
Efficient and scalable synthesis of α,α-disubstituted β-amino amides.

Organic & biomolecular chemistry

Paulsen MH, Engqvist M, Ausbacher D, Strøm MB, Bayer A.
PMID: 27439743
Org Biomol Chem. 2016 Aug 21;14(31):7570-8. doi: 10.1039/c6ob01219a. Epub 2016 Jul 21.

A practical and efficient methodology for the preparation of 2-aminoethyl α,α-disubstituted β-amino amides in three steps from methyl cyanoacetate has been developed. The key step in the synthesis was the chemoselective reduction of the nitrile group in presence of...

Cite
Paulsen MH, Engqvist M, Ausbacher D, et al. Efficient and scalable synthesis of α,α-disubstituted β-amino amides. Org Biomol Chem. 2016;14(31):7570-8doi: 10.1039/c6ob01219a.
Paulsen, M. H., Engqvist, M., Ausbacher, D., Strøm, M. B., & Bayer, A. (2016). Efficient and scalable synthesis of α,α-disubstituted β-amino amides. Organic & biomolecular chemistry, 14(31), 7570-8. https://doi.org/10.1039/c6ob01219a
Paulsen, Marianne Hagensen, et al. "Efficient and scalable synthesis of α,α-disubstituted β-amino amides." Organic & biomolecular chemistry vol. 14,31 (2016): 7570-8. doi: https://doi.org/10.1039/c6ob01219a
Paulsen MH, Engqvist M, Ausbacher D, Strøm MB, Bayer A. Efficient and scalable synthesis of α,α-disubstituted β-amino amides. Org Biomol Chem. 2016 Aug 21;14(31):7570-8. doi: 10.1039/c6ob01219a. Epub 2016 Jul 21. PMID: 27439743.
Copy Download .nbib Format: NLM
Attentional capture and inhibition of saccades after irrelevant and relevant cues.

Journal of ophthalmology

Priess HW, Heise N, Fischmeister F, Born S, Bauer H, Ansorge U.
PMID: 24864194
J Ophthalmol. 2014;2014:585921. doi: 10.1155/2014/585921. Epub 2014 Apr 22.

Attentional capture is usually stronger for task-relevant than irrelevant stimuli, whereas irrelevant stimuli can trigger equal or even stronger amounts of inhibition than relevant stimuli. Capture and inhibition, however, are typically assessed in separate trials, leaving it open whether...

Cite
Priess HW, Heise N, Fischmeister F, et al. Attentional capture and inhibition of saccades after irrelevant and relevant cues. J Ophthalmol. 2014;2014:585921doi: 10.1155/2014/585921.
Priess, H. W., Heise, N., Fischmeister, F., Born, S., Bauer, H., & Ansorge, U. (2014). Attentional capture and inhibition of saccades after irrelevant and relevant cues. Journal of ophthalmology, 2014585921. https://doi.org/10.1155/2014/585921
Priess, Heinz-Werner, et al. "Attentional capture and inhibition of saccades after irrelevant and relevant cues." Journal of ophthalmology vol. 2014 (2014): 585921. doi: https://doi.org/10.1155/2014/585921
Priess HW, Heise N, Fischmeister F, Born S, Bauer H, Ansorge U. Attentional capture and inhibition of saccades after irrelevant and relevant cues. J Ophthalmol. 2014;2014:585921. doi: 10.1155/2014/585921. Epub 2014 Apr 22. PMID: 24864194; PMCID: PMC4016893.
Copy Download .nbib Format: NLM
Comparative investigation of hair with the genRES(®) MPX-SP1, genRES MPX-SP2, and genRES MPX-2 kits.

Forensic science, medicine, and pathology

Anslinger K, Bayer B, Rolf B.
PMID: 25868888
Forensic Sci Med Pathol. 2007 Mar;3(1):41-4. doi: 10.1385/FSMP:3:1:41.

In recent years there has been considerable improvement in short-tandem repeat (STR) investigations of hair, which were previously marred by small amounts of nuclear DNA and its degradation. This study examined the suitability of two STR kits with shortened...

Cite
Anslinger K, Bayer B, Rolf B. Comparative investigation of hair with the genRES(®) MPX-SP1, genRES MPX-SP2, and genRES MPX-2 kits. Forensic Sci Med Pathol. 2007;3(1):41-4doi: 10.1385/FSMP:3:1:41.
Anslinger, K., Bayer, B., & Rolf, B. (2007). Comparative investigation of hair with the genRES(®) MPX-SP1, genRES MPX-SP2, and genRES MPX-2 kits. Forensic science, medicine, and pathology, 3(1), 41-4. https://doi.org/10.1385/FSMP:3:1:41
Anslinger, K, et al. "Comparative investigation of hair with the genRES(®) MPX-SP1, genRES MPX-SP2, and genRES MPX-2 kits." Forensic science, medicine, and pathology vol. 3,1 (2007): 41-4. doi: https://doi.org/10.1385/FSMP:3:1:41
Anslinger K, Bayer B, Rolf B. Comparative investigation of hair with the genRES(®) MPX-SP1, genRES MPX-SP2, and genRES MPX-2 kits. Forensic Sci Med Pathol. 2007 Mar;3(1):41-4. doi: 10.1385/FSMP:3:1:41. PMID: 25868888.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 479 entries